Oroboros Bio
Cambridge, US · Founded 2017 · Delaware corporation
Founders & leadership
RS
Raffaella SquilloniNamed on SEC filing
RA
Robert Alexander Wesselhoeft IVNamed on SEC filing
SS
Sarah SilvergleidNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5M disclosed across 1 round · 2019
▶$5MraisedAug 2019 · 6 investors · PharmaceuticalsRule 506(b)
▶$5MraisedAug 2019 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Raffaella SquilloniExecutive Officer, Director
- Robert Alexander Wesselhoeft IVExecutive Officer, Director
- Sarah SilvergleidExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $5M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Oroboros Bio raised?
- Oroboros Bio has disclosed $5M raised across 1 round.
- Where is Oroboros Bio headquartered?
- Oroboros Bio is headquartered in Cambridge, US.